Update on contingency planning for no-deal Brexit

RNS Number : 5357Q

Surgical Innovations Group PLC

20 February 2019

 

Surgical Innovations Group plc

("Surgical Innovations" or "the Company")

Update on contingency planning for no-deal Brexit

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, provides an update on contingency planning for the possibility of the U.K. leaving the EU without an appropriate Withdrawal Agreement.

On 15 February 2019, BSI Netherlands confirmed the successful reassignment of all of the Company's product certification from BSI Notified Body 0086 (U.K.) to the Netherlands Notified Body 2797.

Nigel Rogers, Executive Chairman of SI Group, stated: "Amidst speculation in the weekend press of possible disruption to the approvals status of medical devices across the EU following a no-deal Brexit, it is reassuring that we have taken this important precaution. Our first priority is to protect the integrity of our regulatory approvals for the EU market, and this will serve to reassure our distribution partners and end users of continuity in coming months."

For further information contact:

Surgical Innovations Group Plc	www.sigroupplc.com
Nigel Rogers, Executive Chairman	Tel: [phone]
Melanie Ross, COO and CFO
Walbrook PR (Financial PR & Investor Relations)	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]
N+1 Singer (Nominated Adviser and Broker)	[phone]
Richard Lindley
Rachel Hayes

 

END

 

 

UPDEAPANFSENEFF